Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

H.C. Leffers; Mikkel Østergaard; Bente Glintborg; N.S. Krogh; U. Tarp; T. Lorenzen; Annette Hansen; M.S. Hansen; L. Dreyer; M.S. Jakobsen; Merete Lund Hetland

Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

H.C. Leffers, Mikkel Østergaard, Bente Glintborg, N.S. Krogh, U. Tarp, T. Lorenzen, Annette Hansen, M.S. Hansen, L. Dreyer, M.S. Jakobsen, Merete Lund Hetland

Original language	English
Journal	Arthritis & Rheumatism
Volume	64
Issue number	10 suppl.
Pages (from-to)	S543
Number of pages	1
ISSN	0004-3591
Publication status	Published - 2012

Access to Document

http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991

Cite this

Leffers, H. C., Østergaard, M., Glintborg, B., Krogh, N. S., Tarp, U., Lorenzen, T., Hansen, A., Hansen, M. S., Dreyer, L., Jakobsen, M. S., & Hetland, M. L. (2012). Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry. Arthritis & Rheumatism, 64(10 suppl.), S543. http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991

Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry. / Leffers, H.C.; Østergaard, Mikkel; Glintborg, Bente et al.

In: Arthritis & Rheumatism, Vol. 64, No. 10 suppl., 2012, p. S543.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Leffers, HC, Østergaard, M, Glintborg, B, Krogh, NS, Tarp, U, Lorenzen, T, Hansen, A, Hansen, MS, Dreyer, L, Jakobsen, MS & Hetland, ML 2012, 'Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.', Arthritis & Rheumatism, vol. 64, no. 10 suppl., pp. S543. <http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=789&id=101991>

@article{1e97b3c0473c4b519f9efe62534826a1,

title = "Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.",

author = "H.C. Leffers and Mikkel {\O}stergaard and Bente Glintborg and N.S. Krogh and U. Tarp and T. Lorenzen and Annette Hansen and M.S. Hansen and L. Dreyer and M.S. Jakobsen and Hetland, {Merete Lund}",

year = "2012",

language = "English",

volume = "64",

pages = "S543",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "10 suppl.",

}

TY - ABST

T1 - Two-year drug survival and treatment effect of abatacept and tocilizumab in the treatment of rheumatoid arthritis in routine care. Results from the nationwide Danish Danbio Registry.

AU - Leffers, H.C.

AU - Østergaard, Mikkel

AU - Glintborg, Bente

AU - Krogh, N.S.

AU - Tarp, U.

AU - Lorenzen, T.

AU - Hansen, Annette

AU - Hansen, M.S.

AU - Dreyer, L.

AU - Jakobsen, M.S.

AU - Hetland, Merete Lund

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 2326-5205

VL - 64

SP - S543

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 10 suppl.

ER -